Back to OPTR Stock Lookup

OPTR Related Analyst Ratings

May 10, 2013 07:59 AM Baird Downgrades Optimer Pharmaceuticals (OPTR) to Neutral

May 10, 2013 07:35 AM Needham & Company Downgrades Optimer Pharmaceuticals (OPTR) to Hold on Weaker Dificid Sales; Says Takeover Hopes Dim

Apr 3, 2013 07:48 AM Cantor Fitzgerald Downgrades Cubist Pharmaceuticals (CBST) to Sell; Doesn't See Deal for Optimer (OPTR)

Mar 1, 2013 08:17 AM JMP Securities Downgrades Optimer Pharmaceuticals (OPTR) to Market Perform

Feb 6, 2013 05:41 PM Baird Starts Optimer Pharmaceuticals (OPTR) at Outperform, $16 PT

Oct 9, 2012 01:10 PM Jefferies Keeps Optimer (OPTR) at Buy as CEO Makes Plans For Growth

Oct 9, 2012 08:19 AM UPDATE: Oppenheimer Downgrades Optimer Pharmaceuticals (OPTR) to Perform, Questions About Near-Term Growth

Oct 4, 2012 02:48 PM Morgan Stanley Starts Optimer Pharmaceuticals (OPTR) at Underweight

Sep 19, 2012 08:02 AM Leerink Swann Starts Optimer Pharmaceuticals (OPTR) at Outperform

Sep 18, 2012 06:45 AM BofA/Merrill Lynch Downgrades Optimer Pharmaceuticals (OPTR) Two-Notches to Underperform

Sep 6, 2012 09:20 AM Needham & Company reiterates a 'Buy' on Optimer Pharmaceuticals (OPTR); Generic Vancomycin in U.S. Appears to have Minimal Impact

Aug 3, 2012 10:36 AM Needham & Company Reiterates a 'Buy' on Optimer Pharmaceuticals (OPTR); Raising Q4 on Dificid Use in Medicare In-Patient Cases

Aug 1, 2012 09:54 AM Baird Maintains an 'Outperform' on Optimer Pharmaceuticals (OPTR); Staying Put Despite Q2 Disappointment

Aug 1, 2012 09:16 AM Canaccord Genuity on Optimer Pharmaceuticals (OPTR): June Blip, But Trends Remain Strong & Doctors Are Interested

Aug 1, 2012 08:00 AM Needham & Company Defends on Optimer (OPTR); Favorable Long-Term Trend Intact

Jul 18, 2012 01:03 PM Needham & Company Maintains a 'Buy' on Optimer Pharmaceuticals (OPTR); Q2 Preview

Jul 12, 2012 09:12 AM Canaccord Genuity Assumes Coverage on Optimer Pharmaceuticals (OPTR) at Buy; Near Term Growth Driven by Unmet Need

Jun 15, 2012 07:20 AM SunTrust Starts OPTR, ACAD, PCYC, TSRX, FURX, PYBI at Buy, ARQL at Neutral

May 14, 2012 11:04 AM ThinkEquity Assumes Optimer Pharma (OPTR) at Buy, Sets $25 Price Target

May 11, 2012 08:18 AM Needham & Company Reiterates a 'Buy' on Optimer Pharmaceuticals (OPTR); Dificid Hits Sales Goal under Cubist Collaboration

Apr 9, 2012 03:00 PM Needham & Company reiterates a 'Buy' on Optimer Pharmaceuticals (OPTR); Mgmt Changes Not Related to Dificid

Apr 9, 2012 12:58 PM JMP Says Executive Removals Will Not Materially Impact Optimer (OPTR)

Mar 12, 2012 12:59 PM Baird Maintains an 'Outperform' on Optimer Pharmaceuticals (OPTR); Dificid Survey Suggests Good Growth Opportunity

Mar 8, 2012 07:50 AM Needham & Company Reiterates a 'Buy' on Optimer Pharmaceuticals (OPTR); Q4 Dificid Sales In Line.

Mar 6, 2012 07:24 AM Needham & Company Reiterates a 'Buy' on Optimer Pharmaceuticals (OPTR); Adjusted Estimates Ahead of Q4 Results

Jan 18, 2012 09:31 AM Canaccord Genuity Reiterates a 'Buy' on Optimer Pharmaceuticals (OPTR) on Continued Positive Script Trends and Aggressive Strategy

Jan 6, 2012 10:34 AM Needham & Company Reiterates a 'Buy' on Optimer Pharmaceuticals (OPTR); 2012 Preview

Dec 23, 2011 07:35 AM Needham & Company 2012 Biotech Preview

Dec 9, 2011 07:38 AM WJB Capital Starts Optimer Pharmaceuticals (OPTR) at Hold

Dec 6, 2011 09:10 AM Canaccord Genuity Reiterates a 'Buy' on Optimer Pharmaceuticals (OPTR); Analyst Day Takeaways

Dec 6, 2011 08:15 AM Baird Maintains an 'Outperform' on Optimer Pharmaceuticals (OPTR); Analyst Day Takeaways

Dec 6, 2011 07:47 AM Needham & Company Reiterates a 'Buy' on Optimer Pharmaceuticals (OPTR); Investor Day Review

Nov 4, 2011 11:28 AM Canaccord Genuity Maintains a 'Buy' on Optimer Pharmaceuticals (OPTR); Q3/11 Update: Dificid Sales Surpass Expectations

Nov 4, 2011 07:06 AM Baird Maintains an 'Outperform' on Optimer Pharmaceuticals (OPTR); Q3-11: Dificid A-OK

Oct 25, 2011 11:47 AM Canaccord Genuity Q3 Biotech Results Preview

Oct 20, 2011 08:42 AM Canaccord Genuity Maintains a 'Buy' on Optimer Pharmaceuticals (OPTR); DIFICID Uptake Appears Steady

Sep 29, 2011 01:15 PM Needham & Company Reiterates 'Buy' on Optimer Pharmaceuticals (OPTR); Collaborator/Competitor Cubist Confirms Plans to Bring CB-315 into Phase 3

Sep 22, 2011 02:52 PM Needham & Company Maintains a 'Buy' on Optimer Pharmaceuticals (OPTR); Dificid Growth Offers Further Appreciation in Stock Price

Sep 22, 2011 02:13 PM Needham & Company Maintains a 'Buy' on Cubist Pharmaceuticals (CBST); Favorably Inclined Towards the Stock

Sep 21, 2011 07:25 AM Brean Murray Carret & Co. Starts Optimer Pharmaceuticals (OPTR) at Buy; Dificid Launch Going Well

Sep 13, 2011 08:33 AM Canaccord Genuity Maintains a 'Buy' on Optimer Pharmaceuticals (OPTR); DIFICID Launch Starts Strong

Aug 8, 2011 07:17 AM Citadel Securities Starts Optimer Pharmaceuticals (OPTR) at Neutral; Expect Difficult Dificid Launch

Jun 1, 2011 07:15 AM Baird Lifts Price Target On Optimer (OPTR) On Premium Price and Confidence About Label

May 31, 2011 10:31 AM Needham & Company reiterates a 'Buy' on Optimer Pharmaceuticals (OPTR); Dificid Approved by the FDA

May 31, 2011 09:21 AM Canaccord Genuity Maintains a 'Buy' on Optimer Pharmaceuticals (OPTR); Eyes on Launch Following DIFICID Approval

May 19, 2011 11:09 AM Canaccord Genuity Reiterates a 'Buy' on Optimer Pharmaceuticals (OPTR); Model Revisions Ahead of DIFICID Launch

May 17, 2011 07:29 AM ThinkEquity Starts Optimer Pharmaceuticals (OPTR) at Buy

Apr 6, 2011 11:01 AM Baird Maintains an 'Outperform' on Optimer Pharma (OPTR); More than One Way to Say “Superior”? FDA Panel Recommends Fidaxomicin Approval

Apr 6, 2011 09:39 AM Needham & Company Reiterates a 'Buy' on Optimer Pharmaceuticals (OPTR); Positive Discussion at Fidaxomicin FDA AdCom Meeting, Expect Approval Next Month

Apr 6, 2011 08:20 AM Canaccord Genuity Maintains a 'Buy' on Optimer Pharmaceuticals (OPTR); Fidaxo Wins FDA Panel Support

Back to OPTR Stock Lookup